A radioenzymatic assay and a "high-performance" liquid chromatographic assay for chloramphenicol were compared by using 52 patient specimens, 24 mock unknowns, and 13 quality control samples. Both methods were found to be rapid, precise, accurate, and sensitive, and either would be suitable for monitoring chloramphenicol concentrations in small volumes of serum. Linear regression analysis of serum chloramphenicol concentrations in patients receiving chloramphenicol succinate yielded a regression equation of Y = 1.04X + 0.274 (X = highperformance liquid chromatographic assay; Y = radioenzymatic assay), with a correlation coefficient of 0.971.
One consequence of the recognition of a high prevalence of ampicillin-resistant invasive Haemophilus influenzae is that chloramphenicol is being administered to infants and children with increased frequency. Sophistication in neonatal intensive care has been accompanied by an increasing prevalence of neonatal nosocomial infections; often these are due to aminoglycosideresistant enteric gram-negative organisms. Guidelines for the use of chloramphenicol are more than 20 years old and were developed with relatively crude assays in low-birth-weight infants whose physiology was vastly different from that of smaller premature infants today. Contemporary studies have demonstrated a marked interpatient variation in drug disposition. Accurate serum chloramphenicol quantitation is necessary for individualization of patient dose to produce serum concentrations in the therapeutic range (2) .
Older methods of quantitating chloramphenicol have depended on its biological activity or detecting its aromatic nitro moiety. Chemical detection of the aromatic nitro group relied on reduction to an amine and subsequent diazotization (1). This method does not distinguish between the administered pro-drug (chloramphenicol succinate or palnitate esters) and various metabolites, including chloramphenicol glucuronide. Quantitation of only the biologically active drug is accomplished with the microbiological bioassay. However, there is a large inherent error in this method (7) , and it requires that the test organism be resistant to (or unaffected by) other concomitantly administered antibiotics (3). In addition, an overnight incubation is often required; this precludes rapid individualization of dosage and can lead to in vitro hydrolysis of 3'-esters to biologically active compounds.
Contemporary methods utilize gas-liquid chromatography (4) and "high-performance" liquid chromatography (HPLC) (5) or specific radioenzymatic (REA) techniques (8) . The gasliquid chromatographic method, although specific and sensitive, requires tedious extraction and derivatization procedures. The HPLC method is advantageous in that it allows quantitation of both chloramphenicol and its prodrug form, chloramphenicol succinate. Further, the method requires only 25 pl of serum, and instrumentation is available to automate the analysis. However, care should be exercised to assure accuracy by ascertaining the specificity of the eluting peaks by using a technique such as dual-wavelength monitoring (5) . The REA, modified from Robison et al. (6) and Smith and Smith (8) , is easily adaptable to batch analysis, is specific for biologically active chloramphenicol, and requires only 10 pl of sample. A previous disadvantage of the REA was the lack of commercial availability of the primary reagent, chloramphenicol acetyltransferase (at the time this paper was submitted, PL-Biochemical, Milwaukee, Wis., announced the availability of this reagent). Since both HPLC and REA procedures could, potentially, provide rapid, sensitive, and accurate determinations of chloramphenicol levels in serum, we decided to compare the quality of these methods. We report here their comparison using patient specimens, mock unknowns, and quality control samples. (6) in which standards prepared in serum contained 25% more apparent drug than those prepared in other physiological fluids.
MATERIALS AND METHODS
The HPLC assay was performed by the method of Petersdorf et al. (5) , with the following modifications. The aqueous part of the mobile phase was adjusted to pH 3.5 instead of pH 7.0, the internal standard was pnitropropionanilide (details for preparation of this compound are available on request), and the column effluent was monitored simultaneously at 254 and 280 nm. These modifications of the original procedure were made so that chloramphenicol succinate could be measured in the same assay with chloramphenicol and are not required for the routine therapeutic monitoring of chloramphenicol. The interrun precision was assessed by including the 5.0-and 15.0-,ug/ml quality control samples with every run of HPLC and REA. Calculation of the mean, standard deviation, and coefficient of variation for the two concentrations in each assay for 13 separate runs yielded the results shown in Table 3 . Figure 1 depicts the comparison of the HPLC and REA methods using 52 patient specimens. Regression analysis indicates a high degree of correlation with no significant bias.
RESULTS

DISCUSSION
Quick and accurate determination of chloramphenicol is needed to avoid toxicity because of a wide variation in individual patient pharmacokinetics. The microbiological assay, with its large inherent error and the required long incubation time (more than 6 h), is not ideal for clinical use when the patient's physiology is rapidly changing. The two methods described, HPLC and REA, allow for results to be available within 1 h after the sample is obtained, and the error with either method is less than 10%. This makes possible daily individual dosage adjustments for patients receiving chloramphenicol.
The accuracy, precision, and sensitivity show no significant differences between the two methods. The high degree of correlation (r = 0.971) and lack of significant bias, as indicated by the regression equation, between the two methods when serum chloramphenicol was determined on patient samples suggests that either method may be used for routine analysis. Therefore, preference of the two methods should be based on availability of equipment, reagents, and technical support. 
